The effect on survival of continuing chemotherapy to near death.
about
Integrated Palliative Care and Oncologic Care in Non-Small-Cell Lung CancerLongitudinal patterns of cancer patient reported outcomes in end of life care predict survivalUse of chemotherapy at the end of life in Turkey.The association between individual income and aggressive end-of-life treatment in older cancer decedents in Taiwan.Time from last chemotherapy to death and its correlation with the end of life care in a referral hospitalDrugs, cancer and end-of-life care: a case study of pharmaceuticalization?Processes of discontinuing chemotherapy for metastatic non-small-cell lung cancer at the end of lifeImpact of aggressive management and palliative care on cancer costs in the final month of lifeThe Palliative-Supportive Care Unit in a Comprehensive Cancer Center as Crossroad for Patients' Oncological PathwayDeterminants for aggressive end-of-life care for oral cancer patients: a population-based study in an Asian country.Survival among non-small cell lung cancer patients with poor performance status after first line chemotherapy.Care of cancer patients at the end of life in a German university hospital: A retrospective observational study from 2014.Population-based trends in systemic therapy use and cost for cancer patients in the last year of life.Chemotherapy Use, Performance Status, and Quality of Life at the End of LifeThe "good planning panel".Persuasive Interventions for Controversial Cancer Screening Recommendations: Testing a Novel Approach to Help Patients Make Evidence-Based Decisions.Clinician perceptions of care difficulty, quality of life, and symptom reports for lung cancer patients: an analysis from the Symptom Outcomes and Practice patterns (SOAPP) study.Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study.Hospice in end-of-life patients with cancer: does it lead to changes in nonhospice health care utilization after stopping cancer treatment?Palliative care needs, symptoms, and treatment intensity along the disease trajectory in medical oncology outpatients: a retrospective chart review.Early integration of palliative care services with standard oncology care for patients with advanced cancer.The Victorian Lung Cancer Registry pilot: improving the quality of lung cancer care through the use of a disease quality registry.Chemotherapy at end-of-life: an integration of oncology and palliative team.Social determinants, multimorbidity, and patterns of end-of-life care in older adults dying from cancer.Pattern and characteristics of advanced cancer patients admitted to hospices in Italy.Palliative care and advance care planning for pancreas and other cancers.End-of-life care for hospitalized patients with metastatic melanoma in France: a nationwide, register-based study.Patterns of health services utilization in the last two weeks of life among cancer patients: Experience in an Australian academic cancer center.Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in Australia.Comparison of the Treatments of Patients With Cancer in Their Last 6 Months Between ICU and Cancer Center.Active treatment of patients with "incurable disease": what's the point?Impact of Palliative Chemotherapy and Travel Distance on Hospice Referral in Patients With Stage IV Pancreatic Cancer: A Retrospective Analysis Within a Veterans Administration Medical Center.Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway.Chemotherapy Use at the End of Life in Uganda.Characteristics and care pathways of advanced cancer patients in a palliative-supportive care unit and an oncological ward.Characteristics of patients with an unplanned admission to an acute palliative care unit.The Role of Palliative Care in Oncology.Chemotherapy in the last 30 days of life of advanced cancer patients.Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies.The impact of specialized palliative care on cancer patients' health-related quality of life: a systematic review and meta-analysis.
P2860
Q26749199-9F6E2C32-1759-4874-983F-0A1C80EFF3C8Q30278080-724FB926-73AA-409F-A12F-304BAFC1D466Q34586853-E67A9C3A-7FF0-426A-BBAD-A80BF8E05FDFQ34942335-ADE4319F-E9B6-47D0-A044-86601C9F4F15Q35188889-23019B4C-C8D5-43BA-AC67-9D555D7E804BQ35223735-29AFD0F6-3091-476E-9419-3389725259F5Q35625697-EC8E8CF7-26E6-406F-A510-BE09C9DE9AC1Q36030672-18B20FC5-13EF-4569-8C48-79BBC334476BQ36058951-EEAEF7C0-8C10-46CD-A178-4E7FB15E25DFQ36153369-181953F1-FA4D-48AA-A52A-E47E8C299267Q36177162-9FD5FCD1-3B8E-4077-A8B9-28AEE94A3C76Q36338117-0123A914-5B0D-4E65-9EB0-A1A35E11ED02Q36658837-F233C9BC-657D-486A-B72C-4EAEE2947520Q36790047-0CA92EA2-897A-450B-BD03-3DFA784406F0Q36930738-85032FD3-D7F9-4089-9669-A0062904E97FQ37567500-F6BF33D3-022F-4554-B44B-FCC98845B2C7Q37606767-25C9EEFB-7D17-422D-B444-16E9A43E92DBQ37617335-0B6E0F8E-AD46-4338-863F-F61C5209738FQ37735545-C236A590-E7D9-4DB2-9EDF-200512D967A5Q38076323-0377A8F0-BB5D-40FC-9E7C-6D0BFBF1412CQ38121761-F4787EBA-D094-4695-8D61-2293BB6327F0Q38218370-B53D4F71-5E35-46E2-AC40-DED7F0019565Q38647053-A8E5A324-F8E4-471E-9C88-7DDEDD7CFF1EQ39059648-436ABA0A-1F98-4728-B8BC-015B3E03516AQ39240460-DBA3A4C2-9BE4-4346-A3F0-FE63BFD523C0Q39433192-B4F010C3-7DE5-4F53-817B-C8C5DE102D4FQ39869759-11C0049D-D107-482B-811D-7FE0105CA1BAQ40127829-8DDF87D1-0C2B-4B76-B9DD-66B55D83BB39Q41076505-BBFCEE56-79A7-4B94-9344-92FBDE7EC20EQ41635023-85B5C9BA-89FE-49B5-90A4-ACC2F8D3771DQ42740873-5A9B29CF-C43B-4E03-9323-EE8BDF4A99DBQ45325653-8BDF6492-6442-49C7-8A87-6F2807F4B7A7Q46650241-6FA29C8E-F130-4117-86AE-A2125B780E4AQ47126905-B57231F1-8DAD-43B7-886A-210592883764Q47192937-62BA3637-2CB6-4CA4-9B22-15670CDB9B29Q47334537-921D7619-2F1A-4114-A87D-9FDD68A4529FQ47563566-F6E9E49F-BB94-4EC7-B2D2-BBE2F4199D80Q47569847-97D5170D-8036-4D18-B7D9-FBE2F45A792CQ47631458-8EEEBE0A-4FE8-4A30-9C29-556555B8AA17Q47685379-9DE1615E-6D0F-43DE-8256-D1F1E6F07408
P2860
The effect on survival of continuing chemotherapy to near death.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The effect on survival of continuing chemotherapy to near death.
@ast
The effect on survival of continuing chemotherapy to near death.
@en
The effect on survival of continuing chemotherapy to near death.
@nl
type
label
The effect on survival of continuing chemotherapy to near death.
@ast
The effect on survival of continuing chemotherapy to near death.
@en
The effect on survival of continuing chemotherapy to near death.
@nl
prefLabel
The effect on survival of continuing chemotherapy to near death.
@ast
The effect on survival of continuing chemotherapy to near death.
@en
The effect on survival of continuing chemotherapy to near death.
@nl
P2093
P2860
P356
P1433
P1476
The effect on survival of continuing chemotherapy to near death.
@en
P2093
Akiko M Saito
Bridget A Neville
Craig C Earle
John Z Ayanian
Mary Beth Landrum
P2860
P2888
P356
10.1186/1472-684X-10-14
P577
2011-09-21T00:00:00Z
P6179
1015659796